Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Grants for Injury Control Research Centers (Panel 3), Funding Opportunity Announcement (FOA) CE12-001, Initial Review, 2549 [2012-842]

Download as PDF Federal Register / Vol. 77, No. 11 / Wednesday, January 18, 2012 / Notices 2549 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES the following meeting of the aforementioned subcommittee: Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Grants for Injury Control Research Centers (Panel 3), Funding Opportunity Announcement (FOA) CE12–001, Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Grants for Injury Control Research Centers (Panel 1), Funding Opportunity Announcement (FOA) CE12–001, Initial Review Dates and Times: February 9, 2012, 1 p.m.–5 p.m. February 10, 2012, 8:30 a.m.–12:30 p.m. Place: CDC, Thomas R. Harkin Global Communications Center, Auditorium B–3, 1600 Clifton Road, NE., Atlanta, Georgia 30333. This meeting is also available by teleconference. Please dial (877) 928–1204 and enter code 4305992. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 200 people. To accommodate public participation in the meeting, a conference telephone line will be available. The public is welcome to participate during the public comment period. The public comment periods are tentatively scheduled for 4:30 p.m.–4:45 p.m. on February 9, 2012 and from 12 p.m.–12:15 p.m. on February 10, 2012. Purpose: The ES will provide counsel to the ACD, CDC, regarding a broad range of public health ethics questions and issues arising from programs, scientists and practitioners. Matters To Be Discussed: Agenda items will include the following: Progress on developing practical tools to assist state, tribal, local, and territorial health departments in their efforts to address public health ethics challenges, approaches for evaluating the impact of public health ethics, strategies for increasing collaboration between public health ethics and public health law, and updates on CDC efforts to build national and international collaboration on public health ethics. The agenda is subject to change as priorities dictate. Contact Person for More Information: For security reasons, members of the public interested in attending the meeting should contact Drue Barrett, Ph.D., Designated Federal Officer, ACD, CDC–ES, 1600 Clifton Road NE., M/S D–50, Atlanta, Georgia 30333. Telephone: (404) 639–4690. Email: dbarrett@cdc.gov. The deadline for notification of attendance is February 3, 2012. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned SEP: Time and Date: 8:30 a.m.–5 p.m., February 21–22, 2012 (Closed). Place: Crowne Plaza Atlanta Perimeter Hotel at Ravinia, 4355 Ashford Dunwoody Rd, Atlanta, Georgia 30346 Telephone: (770) 395–7700. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Grants for Injury Control Research Centers, Panel 3, FOA CE12–001.’’ Contact Person for More Information: Donald Blackman, Ph.D., M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63, Atlanta, Georgia 30341, Telephone (770) 488–0641. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: January 11, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–842 Filed 1–17–12; 8:45 am] BILLING CODE 4163–18–P In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned SEP: Time and Date: 8:30 a.m.–5 p.m., February 21–22, 2012 (Closed). Place: Crowne Plaza Atlanta Perimeter Hotel at Ravinia, 4355 Ashford Dunwoody Road, Atlanta, Georgia 30346 Telephone: (770) 395–7700. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Grants for Injury Control Research Centers, Panel 1, FOA CE12–001.’’ Contact Person for More Information: J. Felix Rogers, Ph.D., M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63, Atlanta, Georgia 30341, Telephone (770) 488–4334. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: January 11, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–848 Filed 1–17–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES tkelley on DSK3SPTVN1PROD with NOTICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)—Ethics Subcommittee (ES) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the CDC announces VerDate Mar<15>2010 16:07 Jan 17, 2012 Jkt 226001 PO 00000 Frm 00042 Fmt 4703 Sfmt 9990 Dated: January 11, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–835 Filed 1–17–12; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\18JAN1.SGM 18JAN1

Agencies

[Federal Register Volume 77, Number 11 (Wednesday, January 18, 2012)]
[Notices]
[Page 2549]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-842]



[[Page 2549]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Grants for Injury Control Research Centers (Panel 
3), Funding Opportunity Announcement (FOA) CE12-001, Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned SEP:

    Time and Date: 8:30 a.m.-5 p.m., February 21-22, 2012 (Closed).
    Place: Crowne Plaza Atlanta Perimeter Hotel at Ravinia, 4355 
Ashford Dunwoody Rd, Atlanta, Georgia 30346 Telephone: (770) 395-
7700.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Grants for Injury Control Research Centers, Panel 3, 
FOA CE12-001.''
    Contact Person for More Information: Donald Blackman, Ph.D., 
M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway NE., 
Mailstop F63, Atlanta, Georgia 30341, Telephone (770) 488-0641.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: January 11, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-842 Filed 1-17-12; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.